Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

2 articles from the last 90 days matching "Multiple Myeloma"

GrantNIH REPORTERMay 11

New NIH Grant: Accelerated Biological Aging and Immunosenescence as Drivers for Racial Disparities in Monoclonal Ga — $558K at Unknown Institution

Researchers are studying why multiple myeloma and a related blood condition called MGUS are more common in African American patients. Scientists received $558,000 to investigate whether faster aging of the immune system might explain these differences. Interestingly, when African American patients get equal healthcare access, they actually do better than other groups, which suggests biology and healthcare access both play a role.

WHY IT MATTERSThis research directly addresses why African American patients develop multiple myeloma at higher rates, which could lead to earlier screening and better prevention strategies for this high-risk population.
Good to knowMultiple MyelomaMonoclonal Gammopathy of Undetermined Significance (MGUS)
🔴 BreakingDrug approvalRSSApr 3

FDA Grants Third Approval Under the National Priority Voucher Program

The FDA has approved a new two-drug combination called Tec-Dara to treat multiple myeloma, a blood cancer that has come back or stopped responding to previous treatments. This approval is special because it was fast-tracked through a program that rewards companies for developing medicines for serious diseases. The combination uses two drugs that work together to help patients whose cancer has already been treated at least once before.

WHY IT MATTERSPatients with relapsed or refractory multiple myeloma now have a new treatment option that combines two drugs shown to work together, potentially offering better outcomes for those who have exhausted earlier treatment lines.
💬 Ask your doctormultiple myeloma

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases